newsfilter
← Latest News
GlobeNewswire·

Heron Therapeutics Announces Second Quarter 2026 Financial Results

– Q2 2026 net revenue of $37.7 million, up 9% from the first quarter of 2026; ZYNRELEF® net revenue grew 35% and APONVIE® net revenue grew 74% year-over-year – Amended credit facility with Hercules Capital: financial